Part of the FDA approval process requires a company to show that they have manufacturing processes in place that can produce their product at commercial scale whilst still meeting GMP. This also includes the FDA inspecting the facility and manufacturing process themselves.
On a normal timeline, companies generally do this in the Phase 3 trials. Given the accelerated approval timelines and the adaptive Phase 2/3 approach that PAA has been given by the FDA, these need to be put in place now. If they get good interim results at the Week 24 readout, the FDA will start reviewing everything else, including the manufacturing.
- Forums
- ASX - By Stock
- Ann: PharmAust makes Head of Manufacturing appointment
Part of the FDA approval process requires a company to show that...
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.0¢ |
Change
0.005(2.44%) |
Mkt cap ! $83.14M |
Open | High | Low | Value | Volume |
21.0¢ | 21.5¢ | 21.0¢ | $56.89K | 270.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 101447 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 71889 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 101447 | 0.210 |
12 | 264533 | 0.205 |
16 | 376824 | 0.200 |
3 | 105564 | 0.195 |
9 | 109505 | 0.190 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 71889 | 4 |
0.220 | 94758 | 3 |
0.225 | 24618 | 3 |
0.230 | 64222 | 3 |
0.235 | 208607 | 4 |
Last trade - 12.36pm 07/06/2024 (20 minute delay) ? |
|
|||||
Last
21.0¢ |
  |
Change
0.005 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
21.0¢ | 21.5¢ | 21.0¢ | 192902 | ||
Last updated 12.36pm 07/06/2024 ? |
Featured News
PAA (ASX) Chart |